Ligandal
Biotechnology ResearchCalifornia, United States11-50 Employees
Ligandal is a biotechnology company based in San Francisco, California, focused on genetic medicine delivered through nanotechnology to enable targeted, personalized therapies. Its work encompasses regenerative medicine, aiming to deliver rapidly acting therapeutics and vaccines for outbreaks, as well as research in immuno-oncology and rare genetic diseases. It emphasizes combining gene delivery with targeting peptides to open new avenues in precision medicine, and is pursuing a peptide-based approach for COVID-19 that does not require gene therapy, with the goal of an antidote-vaccine. It has demonstrated peptide-based delivery of CRISPR, RNA, DNA, siRNA, and various genes or proteins to virtually any cell type. Ligandal is a small to mid-sized biotechnology firm with a global orientation toward enabling personalized medicine via nanomedicine and gene therapies. One notable recent development is the August 2023 appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer.
1-888-653-2347 
support@leadiq.com 
